Skip to main content
JEIL PHARMACEUTICAL CO.,LTD logo

JEIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 271980 ISIN · KR7271980005 KO Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2025-05-29 Governance Information
Country KR South Korea
Listing KO 271980

About JEIL PHARMACEUTICAL CO.,LTD

https://www.jeilpharm.co.kr/english/

JEIL PHARMACEUTICAL CO.,LTD. is a company engaged in the development, manufacturing, and distribution of pharmaceutical products. Its portfolio includes both finished drug products and Active Pharmaceutical Ingredients (APIs). The company produces a diverse range of dosage forms, such as solid medicines (tablets and capsules), patches, and injections, with a strategic focus on becoming a leading manufacturer of injection-based medicines. Committed to developing high-value products, the company operates KGMP-certified manufacturing facilities. Research and development activities are central to its operations, driven by its dedicated R&D center.

Recent filings

Filing Released Lang Actions
기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서) for Jeil Pharmaceutical Co., Ltd. It details the company's governance structure, board composition, shareholder rights, and compliance with governance indicators. This type of report is a standard regulatory filing in South Korea, specifically categorized under Corporate Governance Reports (CGR).
2025-05-29 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Jeil Pharmaceutical Co., Ltd. for the first quarter of 2025 (period ending March 31, 2025). It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM) for Jeil Pharmaceutical. It details the approval of financial statements, election of directors, and other resolutions passed during the meeting held on March 25, 2025. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of outside directors (사외이사). This type of corporate governance disclosure specifically pertains to changes in the board of directors, which falls under the 'Board/Management Information' category.
2025-03-25 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of a company's representative director (CEO). It explicitly lists the names of the outgoing and incoming directors, the reason for the change, and the effective date. This falls directly under the definition of Board/Management Information (MANG).
2025-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Jeil Pharmaceutical. It provides a summary of the audit opinion (unqualified/proper) and key financial data (assets, liabilities, profit/loss) for the fiscal year ending 2024-12-31. While it contains financial data, it is a formal regulatory announcement of the audit report's submission to the exchange (KRX), rather than the full annual report document itself. Therefore, it falls under the category of Audit Report / Information. FY 2024
2025-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.